Hemoglobin A1c Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2027Transparency Market Research (TMR) has published a new report titled, ‘Hemoglobin A1c Testing Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’.
According to the report, the global Hemoglobin A1c Testing Devices market was valued at US$ 1,676.3 Mn in 2018 and is projected to expand at a CAGR of 10.7% from 2019 to 2027.Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=S_id=73900OverviewHemoglobin A1c testing devices are used to determine and monitor hemoglobin A1c levels in diabetic patients.
It is also known as glycosylated hemoglobin test, glycohemoglobin test, glycated hemoglobin test, or A1C.In terms of technology, ion-exchange HPLC segment dominated the market owing to the establishment of this technology as gold standard method of determination of HbA1c due to its excellent specificity and reproducibility.
A clinical study by the company indicated that 205 patients with SC and diabetes were analyzed using immunoassay and HPLC instrument.
High prevalence of different types of diabetes and rise in the geriatric population in the region are some of the factors augmenting the market in North America are expected to drive the market in North America.Asia Pacific is likely to be a highly lucrative market for retinal disorders and it is expected to expand at a high CAGR during the forecast periodRequest for Analysis of COVID19 Impact on Hemoglobin A1c Testing Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19_id=73900Recent approval of HBA1C tests in year 2018 to Drive MarketA1CNow systems developed by PTS Diagnostics got approved in year 2018which provides accurate A1C results in the office or home comes in a convenient 2-test pack or 4-test pack.Abbott laboratories got its Afinion assay product approved which is the first-ever rapid point-of-care test approved to help diagnose diabetes and assess patients’ risk of developing the diseaseBio-Rad Laboratories, Inc product VARIANT II System got its approval which offers fully automated high-volume hemoglobin A1c and β-thalassemia testing, with Clinical Data Management Software and a LIS interface.Faster adoption and Increase in point-of-care testing to Drive MarketPoint-of-care testing provides results within time limit, offers consumer convenience, reduces needle stick injuries, and minimizes contaminationIt has also led to development of the smaller devices, portable, and minimally invasive product.
POC laboratories are also considered an easy way of providing clinical microbiology testing for people far away from core laboratories in developed and developing countriesIon-exchange HPLC Segment to Dominate MarketBased on technology, the global Hemoglobin A1c Testing Devices market has been divided into Ion-exchange HPLC, Immunoassay, Boronate Affinity Chromatography, Direct Enzymatic Assay, and others.